scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.TJOG.2015.05.002 |
P698 | PubMed publication ID | 26384048 |
P2093 | author name string | Tai-Ping Lee | |
Ching-Hua Hsiao | |||
Hua-Wei Tseng | |||
Wei-Lun Cheng | |||
P2860 | cites work | Isolation of fetal DNA from nucleated erythrocytes in maternal blood | Q24558688 |
Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum | Q24567463 | ||
Fetal cells in the blood of pregnant women: detection and enrichment by fluorescence-activated cell sorting | Q24598225 | ||
Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood | Q24657306 | ||
First-trimester screening for Down syndrome in France combining fetal nuchal translucency measurement and biochemical markers | Q28209561 | ||
Incidence and outcome of chromosomal mosaicism found at the time of chorionic villus sampling | Q28243169 | ||
Detection of chromosomal aneuploidies in fetal cells isolated from maternal blood using single-chromosome dual-probe FISH analysis | Q28247266 | ||
Intact fetal cell isolation from maternal blood: improved isolation using a simple whole blood progenitor cell enrichment approach (RosetteSep). | Q30943090 | ||
Microfluidics digital PCR reveals a higher than expected fraction of fetal DNA in maternal plasma | Q33360224 | ||
A fully automated immunoassay from whole blood on a disc | Q33449410 | ||
Fetal cells in maternal blood | Q33939113 | ||
Procedural risks versus theology: chorionic villus sampling for Orthodox Jews at less than 8 weeks' gestation | Q34133519 | ||
The triple test as a screening technique for Down syndrome: reliability and relevance | Q34272104 | ||
Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. | Q34385131 | ||
Randomised controlled trial of genetic amniocentesis in 4606 low-risk women | Q34385464 | ||
Microsatellite alterations in plasma DNA of small cell lung cancer patients. | Q34394739 | ||
Microsatellite alterations in serum DNA of head and neck cancer patients | Q34394745 | ||
Noninvasive Fetal Trisomy (NIFTY) test: an advanced noninvasive prenatal diagnosis methodology for fetal autosomal and sex chromosomal aneuploidies | Q34496747 | ||
Density gradient centrifugation compromises bone marrow mononuclear cell yield | Q34510325 | ||
Georg Schmorl on trophoblasts in the maternal circulation | Q34566588 | ||
Pregnancy loss rates after midtrimester amniocentesis | Q34578193 | ||
Molecular aspects of embryonic hemoglobin function | Q34719514 | ||
Determination of fetal chromosome aberrations from fetal DNA in maternal blood: has the challenge finally been met? | Q34921561 | ||
Maternal serum screening for Down's syndrome in early pregnancy | Q35703368 | ||
A microfluidics approach for the isolation of nucleated red blood cells (NRBCs) from the peripheral blood of pregnant women | Q35786191 | ||
The anaemia of cancer: death by a thousand cuts | Q36167596 | ||
Clinical utility of noninvasive fetal trisomy (NIFTY) test--early experience. | Q36353229 | ||
Non-invasive prenatal diagnosis of aneuploidies: new technologies and clinical applications | Q36424760 | ||
Clinical potential for noninvasive prenatal diagnosis through detection of fetal cells in maternal blood | Q36725782 | ||
Mid-trimester amniocentesis fetal loss rate | Q36876576 | ||
Current and emerging techniques of fetal cell separation from maternal blood. | Q37764561 | ||
Novel approaches to manipulating foetal cells in the maternal circulation for non-invasive prenatal diagnosis of the unborn child | Q37866719 | ||
Intrinsic regulation of hemoglobin expression by variable subunit interface strengths | Q37963019 | ||
Microfluidic: an innovative tool for efficient cell sorting | Q38026358 | ||
Non-invasive prenatal testing using cell-free fetal DNA in maternal circulation | Q38183840 | ||
Simultaneous fetal cell identification and diagnosis by epsilon-globin chain immunophenotyping and chromosomal fluorescence in situ hybridization. | Q38439118 | ||
Separation and detection of rare cells in a microfluidic disk via negative selection | Q39630236 | ||
I branching formation in erythroid differentiation is regulated by transcription factor C/EBPalpha. | Q40080846 | ||
Risk evaluation of CVS. | Q40577967 | ||
Second-trimester maternal serum quadruple test for Down syndrome screening: a Taiwanese population-based study | Q43064398 | ||
Percutaneous umbilical blood sampling: indication changes and procedure loss rate in a nine years' experience | Q43715614 | ||
Combined second-trimester biochemical and ultrasound screening for Down syndrome | Q44240075 | ||
Noninvasive prenatal testing for whole fetal chromosomal aneuploidies: a multicenter prospective cohort trial in Taiwan | Q44576378 | ||
Optimal detection of fetal chromosomal abnormalities by massively parallel DNA sequencing of cell-free fetal DNA from maternal blood | Q44645735 | ||
Detection of circulating endothelial cells via a microfluidic disk | Q45202708 | ||
Basic investigation of the lectin method for separation and recovery of nucleated red blood cells in maternal blood, and a study into the frequency of nucleated red blood cells in fetomaternal disorders | Q45287045 | ||
In vivo model to determine fetal-cell enrichment efficiency of novel noninvasive prenatal diagnosis methods. | Q46408212 | ||
Noninvasive prenatal diagnosis of common fetal chromosomal aneuploidies by maternal plasma DNA sequencing. | Q46892061 | ||
Detection of paternally inherited fetal point mutations for beta-thalassemia using size-fractionated cell-free DNA in maternal plasma | Q47391690 | ||
A comparison of the choice of monoclonal antibodies for recovery of fetal cells from maternal blood using FACS for noninvasive prenatal diagnosis of hemoglobinopathies. | Q50633072 | ||
Biochip for separating fetal cells from maternal circulation. | Q50688198 | ||
Identification of nucleated red blood cells in maternal circulation: a second step in screening for fetal aneuploidies and pregnancy complications. | Q50710677 | ||
Disturbed feto-maternal cell traffic in preeclampsia. | Q50891524 | ||
Extended first-trimester screening using multiple sonographic markers and maternal serum biochemistry: a five-year prospective study. | Q51115326 | ||
Training obstetric and family practice residents to give smoking cessation advice during prenatal care | Q51151334 | ||
Characterization of first trimester fetal erythroblasts for non-invasive prenatal diagnosis. | Q52107671 | ||
Hypermethylated RASSF1A in maternal plasma: A universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis. | Q54574187 | ||
Rapid screening of multiple beta-globin gene mutations by real-time PCR on the LightCycler: application to carrier screening and prenatal diagnosis of thalassemia syndromes. | Q54777008 | ||
Presence of fetal DNA in maternal plasma and serum | Q57075132 | ||
UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10–14 weeks of gestation | Q57523616 | ||
Prenatal exclusion of β thalassaemia major by examination of maternal plasma | Q58029823 | ||
Comparision in the yield of fetal nucleated red blood cell between the first-and second-trimester using double density gradient centrifugation | Q58054075 | ||
Optimization of nucleated red blood cell (NRBC) recovery from maternal blood collected using both layers of a double density gradient | Q61021678 | ||
Circulating 'trophoblast' cells in pregnancy have maternal genetic markers | Q67994028 | ||
A randomized comparison of transcervical and transabdominal chorionic-villus sampling. The U.S. National Institute of Child Health and Human Development Chorionic-Villus Sampling and Amniocentesis Study Group | Q68228475 | ||
Antenatal fetal sex determination from maternal blood during early pregnancy | Q70020637 | ||
Chromosome analysis of human amniotic-fluid cells | Q70063171 | ||
Practical and theoretical implications of fetal-maternal lymphocyte transfer | Q70109256 | ||
Routine chromosome analysis on fetal blood microaliquots obtained at fetoscopy | Q71050603 | ||
Distribution of mosaicism in human placentae | Q71131051 | ||
Disappearance of Hb F and i antigen during the first year of life | Q72621682 | ||
Clinical experience: isolating trophoblasts from maternal blood | Q72764170 | ||
Detection of fetal trisomies 21 and 18 from maternal blood using triple gradient and magnetic cell sorting | Q72782157 | ||
Isolation of fetal trophoblasts and nucleated erythrocytes from the peripheral blood of pregnant women for prenatal diagnosis of fetal aneuploides | Q73070404 | ||
Prenatal DNA diagnosis of a single-gene disorder from maternal plasma | Q73074402 | ||
Optimization of the fluorescence in situ hybridization (FISH) technique for high detection efficiency of very small proportions of target interphase nuclei | Q73184245 | ||
Comparison of fetal cell recovery from maternal blood using a high density gradient for the initial separation step: 1.090 versus 1.119 g/ml | Q73599697 | ||
Multiple screening for fetal Down's syndrome with the classic triple test, dimeric inhibin A and ultrasound | Q73828560 | ||
Fetal blood sampling--indication-related losses | Q77482410 | ||
Revisiting the fetal loss rate after second-trimester genetic amniocentesis: a single center's 16-year experience | Q80797568 | ||
ON A NEW KIND OF RAYS | Q80989171 | ||
Evaluation of a soybean lectin-based method for the enrichment of erythroblasts | Q81482855 | ||
Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting | Q83395075 | ||
Fetal loss rate after chorionic villus sampling and amniocentesis: an 11-year national registry study | Q84018877 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 343-9 | |
P577 | publication date | 2015-08-01 | |
P1433 | published in | Taiwanese Journal of Obstetrics & Gynecology | Q26853808 |
P1476 | title | Noninvasive prenatal diagnosis | |
P478 | volume | 54 |
Search more.